Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1968 Sep 1;128(3):469-95.
doi: 10.1084/jem.128.3.469.

The initial lesion in experimental allergic neuritis. A phase and electron microscopic study

The initial lesion in experimental allergic neuritis. A phase and electron microscopic study

K E Aström et al. J Exp Med. .

Abstract

Experimental allergic neuritis (EAN) was produced in rats by the intradermal injection of an emulsion of peripheral nerve in Freund's adjuvant. Early lesions in perfused sciatic nerves were studied by phase, light, and electron microscopy at intervals up to 15 days following immunization. Circulating lymphocytes attached focally to the inner surface of blood vessels, primarily venules, to initiate parenchymal lesion formation. Attached cells had the hand mirror configuration typical of the motile lymphocyte. They subsequently flattened against the endothelial surface and then traversed the vascular wall by sinking into and passing through the cytoplasm of endothelial cells. The transgressor and transgressed cell membranes were intact and both cells retained their integrity. Lymphocytes began to transform and divide intravascularly; these events accelerated extravascularly. Although the migrating cells became larger and more pleomorphic in the perivascular regions, their essential character was in keeping with an origin from circulating lymphocytes. In many lesions, there was fluid with protein, possibly produced by the transformed extravascular cells. The described cellular events precede tissue damage and are likely instrumental in the myelin destruction which follows

PubMed Disclaimer

References

    1. J Immunol. 1966 Aug;97(2):239-47 - PubMed
    1. J Neuropathol Exp Neurol. 1964 Jan;23:109-26 - PubMed
    1. Ann N Y Acad Sci. 1964 Aug 27;116:774-88 - PubMed
    1. J Exp Med. 1966 Apr 1;123(4):747-56 - PubMed
    1. Science. 1964 Dec 25;146(3652):1648-54 - PubMed